Skip to main content
Paul Hendrie, MD, Hematology, Seattle, WA, UW Medicine/University of Washington Medical Center

PaulCurtisHendrieMDPhD

Hematology Seattle, WA

Hematologic Oncology, Myeloproliferative Disorder Hematology-Oncology

Hematology at Seattle Cancer Care Alliance

Dr. Hendrie is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Hendrie's full profile

Already have an account?

Education & Training

  • University of Washington
    University of WashingtonFellowship, Hematology and Medical Oncology, 1998 - 2000
  • Indiana University School of Medicine
    Indiana University School of MedicineResidency, Internal Medicine, 1995 - 1998
  • Indiana University School of Medicine
    Indiana University School of MedicineClass of 1995

Certifications & Licensure

  • WA State Medical License
    WA State Medical License 1998 - 2025

Publications & Presentations

PubMed

Journal Articles

  • Phase 1/2 Trial of Cladribine, High-Dose Cytarabine, Mitoxantrone, and G-CSF with Dose-Escalated Mitoxantrone for relapsed/refractory Acute Myeloid Leukemia or Other H...  
    Kelda M Gardner, Vivian G Oehler, Heather A Smith, Anna B Halpern, Paul C Hendrie, Sarah A Buckley, Roland B Walter, Pamela S Becker, Ryan D Cassaday, Asma Anwar, Bart..., Haematologica

Abstracts/Posters

  • Comparison of Outcomes after Early Hospital Discharge (EHD) Following Intensive Induction Vs. Post-Remission Chemotherapy for Adults with Acute Myeloid Leukemia (AML) ...
    Paul C. Hendrie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Mini- Vs. Regular-Dose CLAG-M (Cladribine, Cytarabine, G-CSF, and Mitoxantrone) in Medically Less Fit Adults with Newly-Diagnosed Acute Myeloid Leukemia (AML) and Othe...
    Paul C. Hendrie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • A Multi-Omic Precision Medicine Clinical Trial in Acute Leukemia
    Paul C. Hendrie, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
  • Join now to see all

Professional Memberships

Hospital Affiliations